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Abstract Sodium overload stiffens vascular endothelial
cells in vitro and promotes arterial hypertension in vivo.
The hypothesis was tested that the endothelial glycocalyx
(eGC), a mesh of anionic biopolymers covering the surface
of the endothelium, participates in the stiffening process.
By using a mechanical nanosensor, mounted on an atomic
force microscope, height (∼400 nm) and stiffness
(∼0.25 pN/nm) of the eGC on the luminal endothelial
surface of split-open human umbilical arteries were
quantified. In presence of aldosterone, the increase of
extracellular sodium concentration from 135 to 150 mM
over 5 days (sodium overload) led the eGC shrink by ∼50%
and stiffening by ∼130%. Quantitative eGC analyses reveal
that sodium overload caused a reduction of heparan
sulphate residues by 68% which lead to destabilization
and collapse of the eGC. Sodium overload transformed the
endothelial cells from a sodium release into a sodium-
absorbing state. Spironolactone, a specific aldosterone
antagonist, prevented these changes. We conclude that the
endothelial glycocalyx serves as an effective buffer barrier
for sodium. Damaged eGC facilitates sodium entry into the
endothelial cells. This could explain endothelial dysfunc-
tion and arterial hypertension observed in sodium abuse.
Keywords Endothelium.Aldosterone.V ascular
dysfunction.Sodium channel.Sodium
Introduction
In many populations worldwide, sodium chloride intake is
in the range of 8 to 15 g per day. This amount contains 3.2
to 6 g/d of sodium which is far beyond human needs [24].
There is evidence that sodium is osmotically inactively
bound to negatively charged organic material [36]. A
potential candidate for such a dynamic sodium store is the
glycocalyx (eGC) of blood vessels, which is a negatively
charged mesh of membranous glycoproteins, proteoglycans,
glycoaminoglycans and associated plasma proteins. Hya-
luronic acid and the negatively charged heparan sulphate
proteoglycans are its major constituents [39]. eGC lacking
hyaluron synthesis lose its vasoprotective function facili-
tating leukocyte adhesion, inflammation and atherosclerosis
[25]. Critical illnesses and major medical interventions can
cause eGC shedding followed by severe endothelial
dysfunction [6, 26, 32]. Sodium is reversibly bound to this
viscoelastic polyelectrolyte [33] and transported via apical
plasma membrane sodium channels (ENaC) into the cells, a
mechanism mediated by aldosterone [20]. Enhanced sodi-
um influx, triggered by small increases in plasma sodium
concentration, directly affects vascular endothelial cells
leading to increased mechanical stiffness and reduced nitric
oxide release [30].
Initially, during sodium overload, i.e. when sodium
intake exceeds the excretory capacity of the kidney, sodium
is retained. Repeated recurrence of this process is consid-
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DOI 10.1007/s00424-011-0999-1ered to be one of the early steps in the pathogenesis of
hypertension and cardiovascular disease [1]. Alternatively, a
persistent increase in the plasma level of aldosterone
renders vascular endothelium stiff and vulnerable [27].
Changes in mechanical stiffness do not necessarily affect
the whole cell, often only the cell's periphery, its “shell” is
involved [17, 18, 28]. This part of the cell is close to 1 μm
thick and comprises the plasma membrane including the
highly dynamic submembranous actin web. With atomic
force microscopy (AFM), it is now possible to measure the
mechanical properties of the cell's shell and to describe salt-
specific alterations that occur only in this distinct portion of
the cell [29]. As a further step, the work at present has now
switched to the soft and barely detectable eGC. Technical
limitations were overcome so that the eGC could be
quantified in terms of height and stiffness. To mimic
physiological conditions, split-open arteries ex vivo were
used for eGC stiffness measurements. The data indicate a
possible role for the eGC in the maintenance of sodium
homeostasis.
Methods
For technical reasons we used endothelia from ex vivo
arteries and two different cell lines. All preparations
respond to mineralocorticoids [11, 19, 22]. In order to
prevent a collapse of the eGC, we added to all experimental
solutions at least 1% fetal calf serum. In culture media we
usually used 20%. In all experiments a basal aldosterone
concentration of 0.1 nM and, if appropriate, a spironolac-
tone concentration of 100 nM were used.
Arteries ex vivo
The preparation of an artery ex vivo obtained from a human
umbilical cord is described in Fig. 1. The resected and split-
open artery can be used for mechanical measurements as
soon as it is tightly attached to the cell-Tak
®-coated glass
surface. The endothelial cell layer is well preserved in this
preparation (over at least 1 week kept in culture) as
indicated by immunostaining of VE-cadherin (Fig. 1, lower
right). These endothelial cells are called human umbilical
artery endothelial cells ex vivo (HUAEC). The mechanical
properties of a similar ex vivo artery preparation have been
described recently [22].
Endothelial cell culture
Bovine aortic endothelial GM7373 cells (DSMZ,
Braunschweig, Germany) were grown in culture as previ-
ously described [30]. Briefly, confluent GM7373 cells [16]
were cultured in T25 culture flasks using DMEM medium
(Invitrogen Corp., Karlsruhe, Germany) with addition of
NaHCO3, penicillin G, streptomycin (Biochrom AG,
Berlin, Germany) and 20% fetal bovine serum (PAA Clone,
Coelbe, Germany). After reaching confluence cells were
split and then cultured on thin (diameter=15 mm) glass
coverslips. These were placed in petri dishes filled with
culture medium with either low (135 mM) or high
(150 mM) sodium. Osmolality was kept constant with
appropriate addition of mannitol to the low-sodium medi-
um. GM7373 cells formed confluent monolayers within
48 h (at 37°C, 5% CO2). For the HUAEC ex vivo
preparation, the same culture media were used as described
above. The EA.hy926 cell line, derived from endothelium
of the human umbilical vein [9], was grown in DMEM
medium containing 10% fetal calf serum (Biochrom AG).
Intracellular sodium measurements
Intracellular sodium measurements were performed on
confluent EA.hy926 cell layers seeded on glass bottom
dishes (Willco Wells, Amsterdam, Netherlands) mounted to
an inverted fluorescence microscope (Zeiss Axiovert 200,
Jena, Germany) and equipped with a CCD camera (Cool-
SNAP; Visitron Systems, Munich, Germany). The AM-
ester of the intracellular sodium probe SBFI (sodium-
binding benzofuran isophthalate; Molecular Probes, Darm-
stadt, Germany) was dissolved in DMSO (5 mM) and
mixed with an equal volume of 25%wt/vol Pluronic-127
dissolved in DMSO. Endothelial cell monolayers on glass
were incubated with a final SBFI concentration of 0.01 mM
in HEPES-buffered medium for at least 3 h at 4°C. For
fluorescence measurements a 75-W Xenon light source and
a 340/380-nm filter set was applied. After loading, EA.
hy926 were perfused at room temperature for 30 min with
dye-free HEPES buffer containing 5 mM glucose, 10 mM
HEPES, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and
135 mM NaCl (low Na
+) or 150 mM NaCl (high Na
+),
respectively. Then, cells were incubated in low or high Na
+
solution containing Heparinase I (1 U/ml; Sigma-Aldrich
Chemie GmbH, Steinheim, Germany) for 20 min, while
fluorescence measurements were taken every 10 s. At the
end of the experiment, intracellular calibration for sodium
was performed as described previously [23].
Extracellular sodium measurements
GM7373 cells were cultured as described above. After
removal of the medium and washing twice with phosphate-
buffered saline, 5.5 ml of HEPES-buffered saline [compo-
sition in mM: 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, and 10
HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid), pH 7.4] containing 0.5 U/ml heparinase I was added
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2) and incubated at
37°C. The culture flasks were placed on a shaker inside the
(CO2 free) incubator and rhythmically shaken along the
longitudinal axis of the flask (0.5 Hz) for 30 min. Low/high
sodium (see above), aldosterone, spironolactone, amiloride,
and the respective solvents were present in the different
media as appropriate. After incubation the respective
supernatants were harvested and centrifuged (134×g), and
the pH titrated to 5.5 by means of 0.1 M HCl. This
strategy was used to release as much sodium as possible
from the binding sites of the heparan sulphate residues.
Finally, sodium was measured by using an electrolyte
analyzer (EML 105; Radiometer, Copenhagen). Aldoste-
rone (d-aldosterone, Sigma-Aldrich) and spironolactone
(Sigma-Aldrich) were dissolved in ethanol (1 mM stock
solution, stored at 4°C). A concentration of 0.1 nM
aldosterone and 100 nM spironolactone was used in the
culture and perfusion media as appropriate. Amiloride
(Sigma-Aldrich), a selective blocking chemical of the ENaC,
was dissolved in water, at a final concentration of 10 μmol/l.
eGC stiffness measurements
Figure 2 schematically describes stiffness measurements in
living vascular endothelium. The figure explains the
method of “mechanical cell sectioning”, from the cell
surface towards the cell interior. In a previous publication,
we described stiffness measurements of the “bulk” cell
membrane (including the glycocalyx, the plasma membrane
and the cortical actin web) and the “bulk” cell [30]. In the
present study we did not measure bulk stiffnesses but
instead exclusively focused on stiffness measurements of
the outer surface layer of the endothelial cells, the eGC.
eGC stiffness of ex vivo arteries was determined with
AFM techniques similar as described previously in detail
for measuring the endothelial cell membrane/cortical web
[28]. The following modifications were necessary for eGC
stiffness measurements: (1) low indentation velocity,
400 nm/s; (2) low loading force, about 200 pN; and (3)
low indentation frequency, 0.2 Hz. AFM cantilevers
(MLCT contact microlevers; spring constant, 0.01 N/m;
V eeco, Mannheim, Germany) with colloidal tips (electrical-
ly uncharged polystyrene spheres, 1 μm in diameter) were
applied [5]. AFM measurements were performed at 37°C
using a Multimode
® AFM with a feedback-controlled
heating device (V eeco). The artery preparation was bathed
in HEPES-buffered solution [standard composition in
millimolars: 135 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2,1 0
HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid), pH 7.4]. Fetal bovine serum (1%) was added in
order to prevent eGC collapse [12, 35]. Sodium (135–
150 mM) was varied as appropriate. Iso-osmolality was
maintained by the addition of mannitol.
Simultaneous AFM stiffness and immunofluorescence
measurements
Stiffness measurements and fluorescence microscopy on
the endothelial glycocalyx were performed by an AFM
(BioScope Catalyst, Bruker, Mannheim, Germany) com-
Fig. 1 Preparation of an artery
ex vivo obtained from a human
umbilical cord. Upper left one of
the two umbilical arteries freed
from the surrounding tissue.
Upper right a glass cover slip,
coated with Cell-Tak® within
the boundaries of the black
circle is positioned underneath
the cut-open artery. Lower left
split-open artery (about 2×
0.5 mm), with the endothelial
surface facing upwards, after
1 week in culture. Lower right
immunostaining of VE-cadherin
in an ex vivo preparation
cultured for 7 days
Pflugers Arch - Eur J Physiol (2011) 462:519–528 521bined with an inverted fluorescence microscope (DMI
6000 B; Leica Microsystems, Wetzlar, Germany). The
mechanical and optical measurements were simulta-
neously performed on living cells in HEPES-buffered
solution, containing 1% FCS (PAA Clone). For the
AFM stiffness measurements soft cantilevers (spring
constant=18 pN/nm; Novascan, Ames, IA, USA) with
spherical tips (sphere diameter=1 μm) and maximal
loading forces in the range of 400 pN were used.
Heparan sulphate of the eGC was quantified by using a
mouse anti-heparan sulphate (10E4 epitope) antibody
(Seikagaku Corporation, Tokyo, Japan). As secondary
antibody, QDot 655 goat anti-mouse antibody conjugate
(Invitrogen, Darmstadt, Germany) was used. The primary
antibody in the dilution of 1:500 was added to living
GM7373 cells maintained in culture medium at 37°C. After
incubation for 30 min, cells were washed 3×5 min with
PBS (PAA Clone) at 37°C. Then the secondary QDot
antibody conjugate was added (1:800). The cells were again
incubated for 30 min and washed 3×5 min in PBS at 37°C.
Then, PBS was exchanged by HEPES-buffered solution,
containing 1% FCS (PAA Clone) and the measurement
started immediately after this procedure. Quantitative
fluorescence microscopy was performed. The QDots (i.e.
fluorescent nanocrystals that virtually do not bleach) were
excited with a 400-nm laser (emission wavelength,
655 nm). The number of bound QDots/area was quantified
at ×100 magnification as previously described [22]. The
amount of stained heparan sulphate was quantified by
counting single Qdots per area (about 5 to 10 cells per
area). In order to account for any variations in cell height,
two to four images at different focal planes per area were
taken and the total amount of Qdots determined. The
fluorescence data were processed with ImageJ, version
1.43U (freeware, http://rsbweb.nih.gov/ij/). Stiffness, height
and heparan sulphate-bound QDots were quantified before
and after addition of heparinase I (45 min incubation,
1 mU/ml). AFM raw data were processed with Punias 3D
version 1.0 release 1.1 (http://punias.voila.net/). For graphical
and statistical exploration, STA TISTICA 8 (StatSoft Inc.,
Tulsa, USA) and OriginPro 8 (OriginLab Corporation,
Northampton, USA) were used.
Glycocalyx staining with Ulex europaeus agglutinin I
EA.hy926 cells were seeded on ∅ 35 mm culture dishes
with glass bottom (Wilco, Amsterdam, Netherlands) and
grown for 5 days in low- and high-sodium medium (in
presence of 0.1 nM aldosterone) until confluence was
reached. Fluorescein-labelled U. europaeus agglutinin I
(V ector Laboratories, Burlingame, USA) in a concentration
of 0.01 mg/ml was added directly to the cell medium. After
10 min of incubation, cells were washed twice with
HEPES-buffered (low sodium/high sodium + 0.1 nM
aldosterone + 1% FCS) solution. For fluorescence, excita-
tion wavelength of 494 nm was used; emission at 518 nm
was measured. Fluorescence microscopy (excitation/emis-
sion wavelengths in nanometers, 494/518) was performed
Fig. 2 Schematic illustration of
the indentation procedure
(mechanical cell sectioning).
The cell is modelled to have
three mechanically measurable
layers, the glycocalyx, the
plasma membrane including the
cortical web and the bulk phase
of the cell cytosol. a The
colloidal AFM tip is positioned
above the living cell.
b Indentation of the glycocalyx
(this mode is used in the present
study). c Indentation of
glycocalyx, plasma membrane
and actin web. d Indentation of
the glycocalyx, the plasma
membrane including the cortical
actin web and the cell cytosol
(bulk cell indentation)
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(×40 magnification; Leica Microsystems). The fluorescence
data were processed with ImageJ (see above).
Results
Nanoindentations disclose a soft endothelial surface layer
In order to measure the stiffness of the extremely soft eGC,
several experimental parameters had to be modified, in
comparison to the standard nanoindentation procedures
(described in methods). Figure 3 shows a representative
force–distance curve. Two slopes can be detected, the first
slope is shallow and the second slope is steep. As indicated
above, the slopes directly reflect the regional (zonal) cell
stiffnesses. Thus, there is a soft outer surface layer
(indicated by the first slope), directly adjacent to a more
stiff layer underneath. Figure 4 displays time-resolved data
from a representative experiment in which heparinase was
applied in order to biochemically characterize the first
surface layer. Within minutes of heparinase treatment, the
stiffness of the outer cell layer decreases by more than 50%
indicating cleavage of heparan sulphate residues. At the
same time, the glycocalyx thickness in this particular
experiment drops from 400 to 200 nm, consistent with the
view that a lack of heparan sulphate residues in this surface
layer leads to a collapse of this structure. Taken together,
this strongly suggests that the first mechanical resistivity
which has to be overcome by the colloidal AFM tip during
the indentation procedure most probably is the endothelial
glycocalyx.
Proof of principle that the endothelial surface layer detected
by AFM is the eGC
To test the assumption that the indentation measurements
indeed are able to disclose the eGC, we combined
mechanical and fluorescence measurements in individual
cells. Using a hybrid AFM fluorescence setup [4, 10], we
measured stiffness/height of the soft surface layer and,
simultaneously in the same cell, the amount of heparan
sulphate using quantitative immunofluorescence. The meas-
urements were performed before and 45 min after heparin-
ase treatment. This approach allows the quantification of
surface layer stiffness, height and heparan sulphate in
Fig. 3 Original tracing representing a force–distance curve performed
on the endothelial surface of an ex vivo artery. The first slope indicates
the stiffness of the very first layer, most likely the endothelial
glycocalyx (eGC). The second slope indicates the stiffness of the
plasma membrane and the cortical actin web. The distance between
the starting point of eGC indentation and the starting point of the
second slope (projected to the x-axis) corresponds to the height
(thickness) of the eGC (in this trace about 200 nm). The insets
illustrate the different positions of the colloidal AFM tip during the
cell indentation process
Fig. 4 Decrease of eGC stiffness in response to heparan sulphate
digestion. Height measurements were derived from the force–distance
curves before and after heparinase treatment. The experiment was
performed in an ex vivo artery
Pflugers Arch - Eur J Physiol (2011) 462:519–528 523individual cells (paired data). The data are displayed in
Fig. 5. It is evident that heparinase treatment leads to a
decrease of stiffness (47%), height (42%) and heparan
sulphate (34%). The decrease of heparan sulphate signifi-
cantly correlates with the decrease in stiffness (Spearman
correlation coefficient=0.72, p<0.001) and height (correla-
tion coefficient=0.38, p<0.001). Taken together the data
strongly support the view that the soft endothelial surface
layer, disclosed by the nanoindentation measurements, is
indeed the eGC.
Sodium alters the eGC
The present study focuses on the mechanical stability of the
eGC. Its mechanical stiffness is about 0.25 pN/nm which is
5 to 10 times smaller than the stiffness of the plasma
membrane (including the submembrane actin web) [28].
eGC stiffness strongly depends upon ambient sodium. eGC
of endothelium, maintained in high-sodium conditions for
5 days, (sodium overload), hardens, and heparinase
treatment is less effective (low sodium, 58% decrease in
stiffness; high sodium, 35% decrease in stiffness). Spiro-
nolactone, a specific aldosterone antagonist added in the
culture medium during the 5-day high-sodium incubation
period, completely prevents the effects of sodium overload,
i.e. the eGC remains soft and avidly responds to heparinase
(Fig. 6).
As indicated in Fig. 3, eGC height and stiffness can be
taken from the force–distance curves of individual cells.
These two parameters are plotted in Fig. 7. When the
sodium concentration has been kept low in the culture
medium for 5 days, eGC is found soft and prominent. In
contrast, when the sodium concentration has been kept high
for 5 days, the eGC hardens and flattens. Again, spirono-
lactone prevents the high-sodium response of the eGC.
Taken together, the data indicate that the eGC structure is
severely altered when the endothelium is chronically
exposed to ambient high sodium.
Fig. 5 Combined AFM fluorescence measurements in living human
vascular endothelial cells (EA.hy926). Relative stiffness (black
symbols) and height (red symbols) values of the endothelial glycocalyx
were plotted as a function of the amount of heparan sulphate before
(100%) and after 45 min of heparinase treatment (normalized mean±
SE, n=7–39 force–distance cycles per cell; each symbol represents
one individual cell). Mechanical (stiffness/height) and immunofluo-
rescence (heparan sulphate) measurements were performed simulta-
neously on individual cells (paired data)
Fig. 6 Time course of changes in eGC stiffness induced by the
addition of heparinase. Experiments were performed in arteries ex
vivo exposed for 1 week to low (135 mM) sodium, high (150 mM)
sodium and high sodium plus spironolactone (100 nM). Aldosterone
(0.1 nM) was present in all media. Stiffness measurements in the
different groups were performed in identical perfusion media (normal
sodium)
Fig. 7 Correlation between eGC stiffness and eGC height. Experi-
ments were performed in arteries ex vivo exposed for 1 week to low
(135 mM) sodium, high (150 mM) sodium and high sodium plus
spironolactone (100 nM). Low-sodium treatment results in a thick and
soft eGC. High-sodium incubation (sodium overload) results in
reduced eGC height and increased eGC stiffness. The latter effects
are blocked by the aldosterone antagonist spironolactone. Aldosterone
(0.1 nM) was present in all media. Stiffness/height measurements in
the different experimental series were performed in identical perfusion
media (normal sodium)
524 Pflugers Arch - Eur J Physiol (2011) 462:519–528Quantifying eGC proteoglycans by fluorescence
measurements
To complement the AFM data and thus gaining more
insight into any specific alterations of the glycocalyx, we
quantified endothelial-specific lectin binding using
fluorescence-labelled U. europaeus agglutinin I (UEA)
and heparan sulphate residues using specific antibodies
labelled with fluorescent quantum dots (nanocrystals). Two
experimental series in cultured human endothelial cells
(EAhy.926 cell line) were performed, one after low-sodium
and one after high-sodium incubation (5 days of incuba-
tion). The data are shown in Fig. 8. There was a dramatic
decrease of heparan sulphate fluorescence in cells incubated
in ambient high sodium indicating a 68% decrease in the
amount of heparan sulphate residues (Fig. 8, upper graph).
This finding may explain the reduced response of eGC
stiffness to heparinase as shown in Fig. 6. In contrast, UEA
binding rather increased in ambient high sodium (by about
21%; Fig. 8, lower graph). This could be explained either
by an absolute increase in lectin binding sites or, more
likely, by a better accessibility of the core protein binding
sites to UEA due to the dramatic heparan sulphate
rarefication that occurred within 5 days of sodium overload.
Taken together, the data indicate that high-sodium treatment
leads to a reduction in eGC heparan sulphate residues. This
destabilizes the eGC structure and finally leads to eGC
collapse.
Endothelial sodium transport depends upon eGC
A sodium assay system was developed to test whether the
eGC is able to store sodium in measurable amounts. Human
vascular endothelial cells (EAhy-926) were cultured for
1 week under three different conditions, low sodium, high
sodium and high sodium + spironolactone. The cells were
then exposed to heparinase for 60 min, and, subsequently,
the change in sodium concentration in the supernatant was
measured. In response to heparinase treatment, endothelial
cells cultured in low-sodium medium release about 16 nmol
sodium per cm
2 into the supernatant (Fig. 9). In contrast,
endothelial cells cultured in high sodium do not show any
net release of sodium but, surprisingly, increase their
content of sodium. Spironolactone prevents this increase.
In addition, intracellular sodium was measured in cells,
cultured in ambient low sodium and high sodium,
before and 20 min after exposure to heparinase. In cells
cultured in low-sodium medium, intracellular sodium
concentration averaged 13.4±2.33 mM and decreased to
8.8±0.93 mM after heparinase treatment (delta sodium=
4.6±1.51 mM, p<0.02). In contrast, in cells cultured in
high-sodium medium, intracellular sodium concentration
Fig. 8 Quantitative analyses of heparan sulphate immunofluorescence
(quantum dots/area). Cells (EA.hy926) were chronically exposed
(5 days in culture) to either ambient low sodium (135 mM) or high
sodium (150 mM). Aldosterone (0.1 nM) was present in all media.
The statistical difference between low sodium and high sodium is
significant (p<0.01, Mann–Whitney U test)
Fig. 9 Heparinase-induced shift of sodium obtained in cultured
bovine endothelial cells from aorta (GM7373 cells). Endothelial
culture exposed to a low-sodium medium for 1 week releases about
16 nmol of sodium per cm
2 into the supernatant within 30 min of
heparinase treatment. In contrast, when the endothelium was incubat-
ed for 5 days in high-sodium medium (sodium overload), 13 nmol of
sodium per cm
2 “disappears” from the supernatant into the endothelial
monolayer after heparinase treatment. Spironolactone (100 nM)
prevents this response. Aldosterone (0.1 nM) was present in all
media. Sodium flux measurements in the different groups were
performed in identical perfusion media (normal sodium)
Pflugers Arch - Eur J Physiol (2011) 462:519–528 525averaged 8.8±1.39 mM and increased to 11.6±1.91 mM
after heparinase treatment (delta sodium=2.8±0.89 mM,
p<0.01 ). Taken together, the data indicate that the eGC is
a barrier limiting sodium movement between blood and
endothelium. The direction of net sodium movement after
heparan sulphate depletion depends on the concentration
of ambient sodium to which cells were chronically
e x p o s e dt od u r i n gc u l t u r e .
Discussion
The eGC serves important functions in the vascular system
[39]. It regulates vascular permeability [34, 37], controls
flow- and pressure- induced mechanotransduction of the
endothelium [40] and plays a potentially crucial role in the
pathogenesis of inflammation [6, 26]. Chemically, the eGC
is an anionic biopolymer with viscoelastic and specific ion-
binding properties [33]. Proteoheparan sulphate macro-
molecules, anchored in the plasma membrane, expose
negatively charged glycosaminoglycan side chains with
binding sites for inorganic cations. Calcium ions control the
conformational structure of the eGC so that sodium ions are
preferentially absorbed [2, 33]. There is evidence that
sodium may play a key role in the regulation of blood flow
and arterial blood pressure. It was shown that small changes
in extracellular sodium evoke large increases of systolic
blood pressure [13]. The eGC was identified as a blood
flow sensor where sodium flux into the endothelial cells
was thought to be a crucial trigger mechanism that initiates
intracellular signalling [33]. More recently, the eGC was
modelled as a mechanotransducer of fluid shear stress
involving the fine actin web located underneath the apical
plasma membrane [31, 40]. Moreover, it was shown that the
“outer shell” of the cell, comprising the eGC, the apical
plasma membrane and the cortical actin web underneath the
apical cell membrane, is an “ion sensitive zone” [28].
Changes in mechanical stiffness of this outer (apical) cell
zone are physiologically relevant since they determine the
deformation of the cell surface induced by shear stress and
thus the release of nitric oxide, one of the major regulators
of vascular tone [29]. In contrast to the fine subapical actin
web that determines “local surface elasticity” and thus nitric
oxide synthase activity, the coarse actin shear fibres located
at the cell basis and anchored to focal adhesions are
essential for the alignment in the direction of flow [3, 8].
The eGC is modified by ambient sodium
In the present study, efforts have been made to evaluate the
height, stiffness and sodium-binding capacity of the eGC.
Stiffness and height were measured in arteries ex vivo in
physiological conditions, and sodium storage capacity was
estimated in cultured endothelial monolayers. Sodium
overload for 5 days hardens and flattens the eGC. This is
disadvantageous for humans, since deterioration of the eGC
initiates a breakdown of the vascular barrier similar to that
in inflammation [6]. Aldosterone sensitizes endothelial cells
to high sodium by inserting epithelial sodium channels into
the plasma membrane [7, 15, 21] which allows sodium to
enter the cells and disturb cellular function [30].
There is an apparent discrepancy between the
heparinase-induced eGC damage (stiffness decrease and
height decrease, Fig. 4) and eGC damage caused by sodium
overload (stiffness increase and height decrease, Fig. 6). In
both experiments the glycocalyx obviously collapses
(height decrease) due to the lack of heparan sulphates. A
possible explanation is that acute heparan sulphate removal
(heparinase treatment for 45 min) leads to eGC collapse
without any structural reorganisation while sodium over-
load for 5 days, paralleled by eGC damage, allows some
still unknown reorganisation processes (e.g. compacting) of
the altered eGC. Gao and Lipowsky [14] made comparable
observations studying post-capillary venules using intravital
microscopy. They showed that the removal of heparan
sulphate causes a collapse of the glycocalyx most likely due
to a breakdown of the fibre matrix. They concluded that the
heparan sulphate residues could provide the structural
support for the eGC.
It is possible that the eGC plays a crucial role as a
barrier for sodium, e.g. when the eGC is prominent
(∼400 nm thick) and endothelial sodium channel expres-
sion is low—a condition most likely achieved in humans
with low salt intake—two barriers in series, namely the
eGC and the plasma membrane, prevent sodium accessing
the endothelial cells. In contrast, when the eGC is virtually
collapsed (<200 nm) and the expression of sodium
channels is high—a condition to be expected in humans
with high salt intake—the two-barrier mechanism increas-
ingly fails and gradually cells may become accessible to
sodium.
eGC is a significant endothelial sodium barrier
Challenging the eGC with heparinase weakens endothelial
barrier function for sodium. After heparinase application,
cells cultured in low-sodium medium for 5 days release
sodium into the extracellular compartment while, in
contrast, cells cultured in high-sodium medium take up
sodium from the extracellular fluid. These sodium flux
measurements (Fig. 9) are paralleled by mirror-like changes
of intracellular sodium. It appears that removal of heparan
sulphate from the eGC unmasks sodium shuffle mecha-
nisms between the blood compartment and the endotheli-
um. Although not yet proven, it is likely that, after removal
of the glycocalyx, the sodium pump (i.e. the sodium/
526 Pflugers Arch - Eur J Physiol (2011) 462:519–528potassium A TPase) is more active in the low-sodium
adapted cells while, in contrast, the passive sodium leak
through sodium channels (directed into the cell) dominates
in the high-sodium adapted cells. It is tempting to speculate
that in the salt-loaded organism, sodium may more easily
move from blood into the perivascular space whereby
escaping renal filtration and subsequently damaging the
whole organism [24].
Clinical perspective
Sodium abuse is common in many populations worldwide,
causing severe health problems. Derived from the present in
vitro experiments, it is tempting to speculate that high
sodium intake weakens the protective eGC buffer barrier in
the human organism. Thus, sodium arriving in the blood
after a salty meal more readily exits the vascular system. It
distributes in the extracellular space where it binds,
osmotically inactive, to negatively charged organic matrices
[36]. Thereby, ingested sodium escapes the immediate
clearance by the kidneys accumulating over time in the
tissue if sodium intake is chronically high. The high sodium
content in the body will finally damage the organism [38].
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